Detalles de la búsqueda
1.
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.
Lancet
; 400(10351): 512-521, 2022 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35964611
2.
Relugolix in Clinical Practice: The Best Route for All?
Oncologist
; 28(8): 647-650, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37162497
3.
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.
Oncologist
; 27(3): 198-209, 2022 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35274710
4.
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide.
Oncologist
; 27(9): 718-e694, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640474
5.
Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single-Dose Administration Under Fasting Conditions in Prostate Cancer.
Oncologist
; 26(9): 729-e1493, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34333820
6.
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial.
Lancet Oncol
; 21(8): 1099-1109, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645282
7.
Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management.
Oncologist
; 25(4): 290-300, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32297436
8.
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer.
Oncologist
; 25(6): 479-e899, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31594913
9.
The Dietary Supplement Health And Education Act: are we healthier and better informed after 27 years?
Lancet Oncol
; 22(7): 915-916, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34197743
10.
11.
The evolving role of immunotherapy in prostate cancer.
Curr Opin Oncol
; 28(3): 232-40, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26977847
12.
First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report.
Front Oncol
; 13: 1126476, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36937405
13.
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide.
Eur Urol Oncol
; 2023 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37858437
14.
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute.
J Clin Oncol
; 40(17): 1949-1957, 2022 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35263120
15.
Anaplastic Features in Advanced Prostate Cancer With and Without DNA Damage Repair Mutations.
Clin Genitourin Cancer
; 19(6): e352-e359, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34116956
16.
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer.
Clin Cancer Res
; 27(5): 1391-1398, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33262136
17.
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response.
Clin Cancer Res
; 27(2): 429-437, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33023952
18.
Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literature.
Clin Case Rep
; 8(1): 24-32, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31998480
19.
Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors.
Cancer Chemother Pharmacol
; 86(4): 475-486, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32897402
20.
Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer.
Front Oncol
; 10: 581801, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33747894